CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Operating activities:
Net loss	$ (6,248)	$ (3,993)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation	5,948	5,805
Non-cash operating lease expense	1,177	1,229
Amortization expense of finance leases	919	909
Stock-based compensation expense	825	738
Amortization of intangible assets	632	632
Deferred tax provision (benefit)	397	(1,084)
Non-cash loss on partial extinguishment of debt	312	0
Unrealized foreign currency gain	(1,378)	0
Other	963	626
Changes in operating assets and liabilities:
Accounts receivable	1,454	14,056
Prepaid expenses and other assets	1,205	(3,653)
Accounts payable, accrued expenses and other liabilities	2,050	(3,056)
Contract liabilities and customer advances	6,341	(699)
Operating lease liabilities	(2,097)	(2,448)
Net cash provided by operating activities	12,500	9,062
Investing activities:
Capitalized internal-use software costs	(5,855)	(5,272)
Purchases of property and equipment	(76)	(379)
Net cash used in investing activities	(5,931)	(5,651)
Financing activities:
Principal payments of term loan	(5,563)	(113)
Principal payments on finance leases	(976)	(871)
Payment of preferred stock and common stock issuance costs	(907)	0
Principal payments on insurance financing	(641)	(620)
Contingent consideration payment at initial value	0	(859)
Payment of financing and debt issuance costs	0	(559)
Other	(50)	0
Net cash used in financing activities	(8,137)	(3,022)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(150)	644
Net (decrease) increase in cash, cash equivalents and restricted cash	(1,718)	1,033
Cash, cash equivalents and restricted cash at beginning of period	26,800	33,468
Cash, cash equivalents and restricted cash at end of period	25,082	34,501
Cash and cash equivalents	22,044	30,969
Restricted cash	3,038	3,532
Total cash, cash equivalents and restricted cash	25,082	34,501
Supplemental cash flow disclosure:
Cash paid for interest on debt, net of amounts capitalized	1,360	1,332
Supplemental disclosures of non-cash investing and financing activities:
Settlement of restricted stock unit liability	1,586	314
Change in accounts payable and accrued expenses related to capital expenditures	988	0
Series B convertible redeemable preferred stock dividends accrued but not yet paid (related parties)	$ 0	$ 4,439